DETERMINANTS OF RESIDUAL EFFECTS OF HYPNOTICS

被引：10
作者：
ROTH, T
ROEHRS, T
机构：
来源：
ACCIDENT ANALYSIS AND PREVENTION | 1985年 / 17卷 / 04期
关键词：
D O I：
10.1016/0001-4575(85)90029-6
中图分类号：
TB18 [人体工程学];
学科分类号：
1201 ;
摘要：
引用
收藏
页码：291 / 296
页数：6
相关论文
共 20 条
[1]   DAYTIME SLEEPINESS AS A CRITERION IN HYPNOTIC MEDICATION TRIALS - COMPARISON OF TRIAZOLAM AND FLURAZEPAM [J].
BLIWISE, D ;
SEIDEL, W ;
KARACAN, I ;
MITLER, M ;
ROTH, T ;
ZORICK, F ;
DEMENT, W .
SLEEP, 1983, 6 (02) :156-163
[2]   PHARMACOKINETICS AND METABOLISM OF VARIOUS BENZODIAZEPINES USED AS HYPNOTICS [J].
BREIMER, DD .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 8 :S7-S13
[3]   NOCTURNAL DETERMINANTS OF DAYTIME SLEEPINESS [J].
CARSKADON, MA ;
DEMENT, WC .
SLEEP, 1982, 5 :S73-S81
[4]  
Greenblatt D J, 1980, Psychosomatics, V21, P9
[5]   KINETICS AND CLINICAL EFFECTS OF FLURAZEPAM IN YOUNG AND ELDERLY NON-INSOMNIACS [J].
GREENBLATT, DJ ;
DIVOLL, M ;
HARMATZ, JS ;
MACLAUGHLIN, DS ;
SHADER, RI .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 30 (04) :475-486
[6]  
GREENBLATT DJ, BRIT J CLIN PHARM
[7]   PSYCHOMOTOR FUNCTION AND PSYCHOACTIVE-DRUGS [J].
HINDMARCH, I .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 10 (03) :189-209
[8]   SEDATIVE-HYPNOTICS AND HUMAN-PERFORMANCE [J].
JOHNSON, LC ;
CHERNIK, DA .
PSYCHOPHARMACOLOGY, 1982, 76 (02) :101-113
[9]  
KALES A, 1975, CLIN PHARMACOL THER, V18, P356
[10]  
KAY DC, 1976, PHARM SLEEP
12